scispace - formally typeset
V

Vinoth Prasanna Gunasekaran

Researcher at Bharathidasan University

Publications -  9
Citations -  120

Vinoth Prasanna Gunasekaran is an academic researcher from Bharathidasan University. The author has contributed to research in topics: Cancer & Reproductive toxicity. The author has an hindex of 6, co-authored 9 publications receiving 68 citations.

Papers
More filters
Journal ArticleDOI

p-Coumaric acid attenuates alcohol exposed hepatic injury through MAPKs, apoptosis and Nrf2 signaling in experimental models

TL;DR: The ameliorative consequence of PCA on ethanol induced oxidative stress and apoptosis was achieved by suppressing the expression of CYP2E1 and overexpressing Nrf2 and its target protein HO-1 in rat liver tissue and PCA was marked to be an effective antioxidant with notable hepatoprotection.
Journal ArticleDOI

p-Coumaric acid ameliorates ethanol–induced kidney injury by inhibiting inflammatory cytokine production and NF–κB signaling in rats

TL;DR: Jp-Coumaric acid is investigated as a promising candidate for ethanol-induced kidney toxicity by restoring antioxidant production and suppressing cellular apoptosis and inhibiting NF-κB expression.
Journal ArticleDOI

Protective effects of p‑coumaric acid on ethanol induced male reproductive toxicity.

TL;DR: Overall, the results showed that PCA mitigates alcohol induced male reproductive toxicity and improves reproductive health in male Wistar rats.
Journal ArticleDOI

Doxorubicin-induced female reproductive toxicity: an assessment of ovarian follicular apoptosis, cyclicity and reproductive tissue histology in Wistar rats.

TL;DR: The results suggest that though doxorubicin is a potential chemotherapeutic drug for many tumors, but the risk of adverse effects on the female reproductive system is there even at low doses.
Journal ArticleDOI

Identification of 2,4-dihydroxy-5-pyrimidinyl Imidothiocarbomate as a Novel Inhibitor to Y Box Binding protein-1 (YB-1) and Its Therapeutic Actions Against Breast Cancer

TL;DR: DPI inhibited YB‐1 nuclear translocation, thereby exhibited anti‐apoptotic, anti‐proliferative and anti‐metastatic activities and increases the therapeutic potential of commercial breast cancer drug doxorubicin.